These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 11926751)
1. Use of cytomegalovirus immune globulin and ganciclovir for the prevention of cytomegalovirus disease in lung transplantation. Zamora MR Transpl Infect Dis; 2001; 3 Suppl 2():49-56. PubMed ID: 11926751 [TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus prophylaxis with ganciclovir and cytomegalovirus immune globulin in liver and intestinal transplantation. Tzakis AG Transpl Infect Dis; 2001; 3 Suppl 2():35-9. PubMed ID: 11926748 [TBL] [Abstract][Full Text] [Related]
3. Combination prophylaxis with ganciclovir and cytomegalovirus (CMV) immune globulin after lung transplantation: effective CMV prevention following daclizumab induction. Weill D; Lock BJ; Wewers DL; Young KR; Zorn GL; Early L; Kirklin JK; McGiffin DC Am J Transplant; 2003 Apr; 3(4):492-6. PubMed ID: 12694074 [TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus immunoglobulin decreases the risk of cytomegalovirus infection but not disease after pediatric lung transplantation. Ranganathan K; Worley S; Michaels MG; Arrigan S; Aurora P; Ballmann M; Boyer D; Conrad C; Eichler I; Elidemir O; Goldfarb S; Mallory GB; Mogayzel PJ; Parakininkas D; Solomon M; Visner G; Sweet SC; Faro A; Danziger-Isakov L J Heart Lung Transplant; 2009 Oct; 28(10):1050-6. PubMed ID: 19782286 [TBL] [Abstract][Full Text] [Related]
6. Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Drugs; ; . PubMed ID: 9664203 [TBL] [Abstract][Full Text] [Related]